3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Sarcoma
1
Gynecologic
1
Conditions
Lung Neoplasms
22
Breast Neoplasms
18
Hematologic Neoplasms
16
Colorectal Neoplasms
13
Prostatic Neoplasms
11
Neoplasms
10
Carcinoma, Non-Small-Cell Lung
10
Pancreatic Neoplasms
9
Hematopoietic and Lymphatic System Neoplasm
9
Anatomic Stage I Breast Cancer AJCC v8
9
Urinary Bladder Neoplasms
6
Ovarian Neoplasms
6
Neoplasm Metastasis
6
Uterine Cervical Neoplasms
5
Squamous Cell Carcinoma of Head and Neck
5
Multiple Myeloma
5
Leukemia, Myeloid, Acute
5
Head and Neck Carcinoma
5
Breast Carcinoma In Situ
5
Triple Negative Breast Neoplasms
4
Stomach Neoplasms
4
Melanoma
4
Hematopoietic and Lymphoid System Neoplasm
4
Head and Neck Neoplasms
4
Carcinoma, Renal Cell
4
Rectal Neoplasms
3
Myelodysplastic Syndromes
3
Mouth Neoplasms
3
Malignant Solid Neoplasm
3
Lymphoma
3
Interventions
Radiotherapy
3
Radiation
3
Paclitaxel
3
Cisplatin
3
Taxes
2
Carboplatin
2
Brachytherapy
2
Standard of Care
1
Practice Guidelines as Topic
1
Platinum
1
1,2-diaminocyclohexaneplatinum II citrate
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Interventional
×
Endometrial Clear Cell Adenocarcinoma
×
Practice Guidelines as Topic
×
Clear all
NCT03422198
2025-12-12
SAVE
University of Utah
Phase 3
Recruiting
188 enrolled
15 charts